Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Fengting Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3750-5673; OpenAlex author ID A5091735131. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper

Papers 11

  1. Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment. Co-author DOI 10.3390/cancers15020474↗
  2. Retraction Note to: LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Co-author DOI 10.1186/s12943-022-01678-7↗
  3. METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma. Last author DOI 10.3389/fcell.2022.759020↗
  4. SLC45A4 promotes glycolysis and prevents AMPK/ULK1-induced autophagy in TP53 mutant pancreatic ductal adenocarcinoma. First author DOI 10.1002/jgm.3364↗
  5. CircMYOF triggers progression and facilitates glycolysis via the VEGFA/PI3K/AKT axis by absorbing miR-4739 in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41420-021-00759-8↗
  6. LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Co-author DOI 10.1186/s12943-018-0845-6↗
  7. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro. Co-author DOI 10.1007/s10620-017-4472-7↗
  8. Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis. First author DOI 10.2147/ott.s146383↗
  9. MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. Co-author DOI 10.1371/journal.pone.0087897↗
  10. Silencing of GATA6 suppresses SW1990 pancreatic cancer cell growth in vitro and up-regulates reactive oxygen species. First author DOI 10.1007/s10620-013-2752-4↗
  11. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance. Co-author DOI 10.3892/ijo.2012.1597↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shineng Zhang · 11 shared papers, 2012–2023 · strength 1.14
  2. Yanyan Zhuang · 10 shared papers, 2012–2023 · strength 1.07
  3. Juanfei Peng · 7 shared papers, 2017–2023 · strength 0.95
  4. Wen‐Ying Chen · 5 shared papers, 2017–2022 · strength 0.50
  5. Sihua Lan · 2 shared papers, 2022–2023 · strength 0.38
  6. Liting Lu · 2 shared papers, 2021–2022 · strength 0.29
  7. Wa Zhong · 1 shared paper, 2023 · strength 0.22
  8. Dandan Zheng · 1 shared paper, 2021 · strength 0.14
  9. Wenbo Chen · 3 shared papers, 2012–2014 · strength 0.12
  10. Yongxun Zhuansun · 2 shared papers, 2012–2017 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.